Aspiriant LLC’s Citigroup C Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$460K Buy
3,551
+781
+28% +$105K 0.01% 258
2026
Q2
$388K Buy
+2,770
New +$361K 0.01% 285
2024
Q2
– Sell
-3,466
Closed -$219K – 290
2024
Q1
$219K Buy
+3,466
New +$193K 0.01% 299
2019
Q3
– Sell
-3,059
Closed -$214K – 213
2019
Q2
$214K Buy
+3,059
New +$205K 0.02% 212

Other funds holding C

Aspiriant LLC's C Position: Q3 2026 in Review

Aspiriant LLC increased its Citigroup (C) stake by 28% in Q3 2026, buying an estimated $105K and bringing the position to 3,551 shares worth $460K. The position accounts for 0.01% of the portfolio, ranked #258.

Aspiriant LLC first reported a position in C in Q2 2019 and has held it in 4 quarters since. 745 funds tracked by Wall St. Rank hold C as of Q3 2026.

  • Aspiriant LLC held 3,551 shares of Citigroup worth $460K as of Q3 2026.
  • Aspiriant LLC bought 781 Citigroup shares in Q3 2026, an estimated $105K.
  • Citigroup made up 0.01% of Aspiriant LLC's portfolio in Q3 2026, its #258 holding.
  • Aspiriant LLC first reported a position in Citigroup in Q2 2019 and has held it in 4 quarters since.
  • 745 funds tracked by Wall St. Rank held Citigroup as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.